(Q46847874)
Statements
1 reference
Select high-risk genetic features predict earlier progression following chemoimmunotherapy with fludarabine and rituximab in chronic lymphocytic leukemia: justification for risk-adapted therapy (English)
1 reference
1 reference
John C Byrd
1 reference
Nyla A Heerema
1 reference
Michael A Caligiuri
1 reference
Michael R Grever
1 reference
Gerard Lozanski
1 reference
John G Gribben
1 reference
Bercedis L Peterson
1 reference
David M Lucas
1 reference
Ben Lampson
1 reference
12 December 2005
1 reference
1 reference
24
1 reference
437-443
1 reference
3
1 reference
Identifiers
1 reference
1 reference